Managing Drug-Drug Interactions—So Many Drugs, So Little Evidence - JAMA Network
Alfehaid et al. analyzed colchicine-related drug-drug interactions (DDIs) in COVID-19 patients, finding no increased risk of adverse events from potential DDIs. The study highlights the need for efficient screening and testing of DDIs using big data and clinical trial repurposing, emphasizing the importance of conservative prescribing and interaction checkers in clinical practice.
Reference News
Alfehaid et al. analyzed colchicine-related drug-drug interactions (DDIs) in COVID-19 patients, finding no increased risk of adverse events from potential DDIs. The study highlights the need for efficient screening and testing of DDIs using big data and clinical trial repurposing, emphasizing the importance of conservative prescribing and interaction checkers in clinical practice.